Business

PARAMOUNT+ SETS MARCH 6 NORTH AMERICAN PREMIERE FOR AWARD-WINNING DOCUMENTARY THE PINK PILL: SEX, DRUGS & WHO HAS CONTROL

Directed By Award-Winning Montreal Filmmaker Aisling Chin-Yee, The Film Ignites A Global Conversation On Women's Health, Power, And Medical Equity Ahead Of

articleParamount Skydance CorporationFebruary 12, 20264/company/paramount-skydance-corporation/news/paramount-sets-march-6-north-american-premiere-for-award-winning-documentary-the-pink-pill-sex-drugs-and-who-has-control
PARAMOUNT+ SETS MARCH 6 NORTH AMERICAN PREMIERE FOR AWARD-WINNING DOCUMENTARY THE PINK PILL: SEX, DRUGS & WHO HAS CONTROL

About this update from Paramount Skydance Corporation

[{"type":"text","content":"Directed By Award-Winning Montreal Filmmaker Aisling Chin-Yee, The Film Ignites A Global Conversation On Women's Health, Power, And Medical Equity Ahead Of International Women's Day Trailer for THE PINK PILL: SEX, DRUGS & WHO HAS CONTROL now available HERE Link to Images HERE TORONTO, Feb. 12, 2026 /PRNewswire/ -- Paramount+ announced today that breakout documentary THE PINK PILL: SEX, DRUGS & WHO HAS CONTROL will premiere in Canada and the U.S. on March 6, ahead of International Women's Day (March 8). Celebrating powerful storytelling about women by women, the bold and boundary-pushing film examines the cultural, scientific, and political battle behind the first United States Food and Drug Administration (FDA) and Health Canada-approved treatment for women's sexual desire. \n \n \n \n \n \n \n \nAt its center is Cindy Eckert, entrepreneur and women's health advocate, whose trademark pink and fearless determination made her a lightning rod in the battle to bring Addyi— which the media dubbed \"female Viagra\"—to market. Eckert confronted gender bias head-on, ultimately winning approval for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women in 2015. This past December, the FDA expanded its approval to include postmenopausal women under 65. The Paramount+ Original THE PINK PILL is directed by award-winning Canadian filmmaker Aisling Chin-Yee (No Ordinary Man, The Rest of Us, Plan B) and produced by Catalyst and Everywoman Studios. Executive Producers are Julie Bristow (Catalyst), Abby Greensfelder (Everywoman Studios), Vibika Bianchi, Aisling Chin-Yee and Joanna Griffiths (Knix). Writers are Chin-Yee and Steve Taylor, who also serves as editor. Director of Photography is Nina Djacic. The film marks the first project from Docs for Change, a collaboration between Catalyst, the Toronto-based studio for woman-identifying creators, and Knix Fund, a philanthropic arm of the game-changing intimates brand Knix. \"Medical sexism knows no borders,\" said Chin-Yee. \"As a Canadian filmmaker, I had the opportunity to shine a rare spotlight on desire, the reclamation of pleasure, and bodily autonomy. This film confronts both cultural and institutional gender bias. My hope is that it sparks meaningful conversations and momentum around how our health is valued and prioritized.\"\"THE PINK PILL: SEX, DRUGS & WHO HAS ...

More updates from Paramount Skydance Corporation